Glutamate modulation of human lymphocyte growth: In vitro studies

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

Peripheral blood mononuclear cell (PBMC) proliferation induced by phytohemagglutinin, or by anti-CD3 alone or plus anti-CD28 monoclonal antibodies (mAb) was inhibited by glutamate (Glu) in a concentration-dependent manner. This inhibition was not reproduced by selective ionotropic Glu receptor agonists, whereas it was potentiated by L-buthionine-(S,R)-sulfoximine, which depletes glutathione (GSH) stores, and counteracted by 2-mercaptoethanol, a preserver of cell thiols. The inhibitory effects of Glu were related to depletion of intracellular GSH stores, since it decreased GSH levels in a concentration-dependent manner. Furthermore, Glu modulated cytokine secretion by anti-CD3 mAb activated PBMC: it increased IFN-γ (+44.3±8.2%) and IL-10 (+31.6±9.7%) secretion, whereas that of IL-2, IL-4, IL-5, and TNF-α was not affected. These data suggest that high levels of Glu, which can be reached in damaged tissues, modulate lymphocyte responses to activating stimuli by favouring polarization of the T helper effector response.

Lingua originaleInglese
pagine (da-a)496-502
Numero di pagine7
RivistaBiochemical and Biophysical Research Communications
Volume318
Numero di pubblicazione2
DOI
Stato di pubblicazionePubblicato - 28 mag 2004

Fingerprint

Entra nei temi di ricerca di 'Glutamate modulation of human lymphocyte growth: In vitro studies'. Insieme formano una fingerprint unica.

Cita questo